NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
25/03/2026
Voltar para busca
Dado oficial do USPTO
DAIICHI-SANKYO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
26/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
07/12/2012
Data de registro
12/05/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/03/2026
Última transação
26/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Tokyo, JP
Examinador
BRADLEY, EVELYN
Localização atual
Historical data usage
Descrição da marca
The mark consists of the stylized wording "DAIICHI-SANKYO" to the right of a partial circle displayed within a circular design.
Titulares e representantes
Titulares
DAIICHI SANKYO COMPANY, LIMITED
Representantes
Bassam N. Ibrahim Buchanan Ingersoll & Rooney, PC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical food preservatives; chemical plasticizers for use as high polymer stabilizers for plastics and paints; synthetic chemical polymer stabilizers for use as light stabilizers for plastics and coatings; chemical additives for use in the manufacture of foods; chemical antioxidants for use in the manufacture of drinkscakesflavoring agentsdairy products and fish paste products; chemical germination controllersgibberellins for grapesoranges and for domestic and agricultural use; diagnostic reagents for in vitro scientific use; diagnostic preparations for in vitro biological testsfor urine and blood testsfor blood glucose testsfor clotting testsall for scientific use; enzyme preparations for use in vitro scientific use; soil conditionerssoil improving agents and plant growth regulators for agricultural use; tetrodotoxins for scientific research use; adhesives not for stationery or household purposes; plant growth regulating preparations; fertilizers; higher fatty acid for use as food additive for food manufacturing; chemical test paper; artificial sweeteners
Classe 5
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseaseatherosclerosisdiabetic nephropathystrokeheart attackhypercholesterolemiadyslipidemiaanemiablood disordersdiabetesthyroid function diseasecanceroncological diseasemetastasisautoimmune diseaseallergybacterial infectionviral infectionfungal infectioninflammationmusculoskeletal disorderspainosteoporosisAlzheimer's diseaseobesityanorexiaurinary and kidney diseaserespiratory diseasegastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use; veterinary drugs for the treatment of distemper in dogsdistomatosis in dogscoccidium in chickens and dysentery in pigs; sanitary preparations for medical use and sanitary preparations for agricultural useherbicidesfungicidesinsecticidesbactericides and rodenticides; oiled paper for medical purposes; facial masks for sanitary purposesnot for medical personnelmasks used for germvirusallergen prevention sold as part of a kit consisting primarily of sanitizing preparations for household use; drug delivery agents in the form of edible wafers for wrapping a dose of powdered medicineunit dose gelatin or starch based dissolvable thin film sold empty for pharmaceuticals; gauze for dressings; unit dose capsules sold empty for pharmaceuticals; eye patches for medical use; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical use; adhesive plasters for medical use; bandages for dressings; collodion for medical use; breast-nursing pads; dental impression material; dental cements; dental abrasives; dental mastics; lactose for pharmaceutical purposes; powdered milk for babies; dietetic beveragesnutritionally fortified beveragesvitamin fortified beverages and mineral fortified beverages adapted for medical purposes; baby foods; edible plant fibersdietary fibers for use as non-nutritive additives for food products to aid digestion; ground flaxseed fibers used in dietary supplements
Classe 42
Technical research in the fields of pharmaceutical productsmedicines and cosmetics; project studiesresearch relating to pharmaceutical productsmedicines and cosmetics; technical project studiesresearch relating to pharmaceutical productsmedicines and cosmetics; research on civil engineering; research and development for others in the fields of pharmaceutical productsmedicines and cosmetics; quality testing in the fields of pharmaceutical productsmedicines and cosmetics; quality evaluation of pharmaceutical productsmedicines and cosmetics; chemical analysis in the fields of pharmaceutical productsmedicines and cosmetics; chemistry services in the nature of chemistry consultation in the fields of pharmaceutical productsmedicines and cosmetics; chemical research in the fields of pharmaceutical productsmedicines and cosmetics; cosmetic research; bacteriological research relating to pharmaceutical preparations and medicine; biological research relating to pharmaceutical preparations and medicine; product research and development in the fields of medical and pharmaceutical preparations and medicines; research and development relating to manufacturing processes in the fields of medical and pharmaceutical preparations and medicines; research and developmentconducting clinical trials for others
Classe 44
Medical clinics; hospitals; health care; medical assistance services; physical therapy; medical nursing services; pharmaceutical advice; plastic surgery; telemedicine services; pharmacists' services to make up prescriptions; veterinary assistance services; providing healthcare advisory services and information in the fields of pharmaceutical preparationspharmaceutical productsmedicinesmedical treatmentdiseases and administration of medicines; preparation and dispensing of medications; medical services; providing information relating to healthcare
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
25/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2026
ES71
TEAS SECTION 71 RECEIVED
03/11/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/05/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
22/05/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/04/2023
INPC
INVALIDATION PROCESSED
06/04/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
14/02/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/01/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
14/06/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
14/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/05/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
11/11/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/05/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/07/2019
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
18/05/2016
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
18/03/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/09/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/09/2015
FIMP
FINAL DISPOSITION PROCESSED
03/09/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/02/2015
PUBO
PUBLISHED FOR OPPOSITION
24/02/2015
GPNX
NOTIFICATION PROCESSED BY IB
19/02/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/02/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/02/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/01/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/01/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
16/01/2015
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
02/01/2015
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
02/01/2015
CNCF
ACTION CONTINUING A FINAL - COMPLETED
02/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/12/2014
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
22/10/2014
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
16/10/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/06/2014
GNFR
FINAL REFUSAL E-MAILED
03/06/2014
CNFR
FINAL REFUSAL WRITTEN
03/06/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/05/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2014
ALIE
ASSIGNED TO LIE
05/05/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2014
RFNT
REFUSAL PROCESSED BY IB
16/11/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/10/2013
RFRR
REFUSAL PROCESSED BY MPU
29/10/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/10/2013
CNRT
NON-FINAL ACTION WRITTEN
28/10/2013
MAFR
APPLICATION FILING RECEIPT MAILED
26/10/2013
DOCK
ASSIGNED TO EXAMINER
22/10/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/10/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
22/10/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/10/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DAIICHI-SANKYO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.